Ceftriaxone for Injection (Hospira, Inc.)

Hazard statements (CLP)

H317

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

OSHA <2 2.1, te itp

2.1 Classification of the substance or mixture

oiiication of of the substance substance or or mixture mixture _ Respiratory sensitization Skin sensitization Category 1 Category 1

Signal word

Danger

Hazard statements

H334 H317 - May cause allergy or asthma symptoms or breathing difficulties if inhaled - May cause an allergic skin reaction

Precautionary statements

P261 - Avoid breathing dust/fume/gas/mist/vapors/spray P272 - Contaminated work clothing must not be allowed P280 - Wear out of the workplace protective gloves/protective Pana - " are on clothing/eye protection/face protection inadequate ventilation wear + ~ IF position respiratory comfortable protection INHALED: If breathing is difficult, remove to fresh ai C) for breathing ' i doctor/physician 342 + P3114 - If experiencing ms air and Keep at rest in a respiratory piratory sym symptoms toms Cal Call a POISON CENTRE or t 2 Inc.) Cc eftriaxone for tn} ‘ection (Hospira, Product Name Prepared: 18 -Jun-2022 water ty of soap and adv ice/attention P302+ P352-1 rash oc! rs: Get medical h it before reuse P333 + P3 43 - If skin irritation oF d clothing and was O Take off contaminate ccordance W ith all lo cal and national regulations P362 + P364 - ainer in P501 - Dispose of contents/cont Valu e has been established for on e or more of the ingredients An Occupational Exposure 2.3. Other

2.3 Other hazards

(see Section 8). with standards for workplace safety, has been prepared in accordance This document of the active substance or its intermediates Note: the inclusion regardless of the potential risk. The pr cautionary statements and warnings included méy not apply in all cases. Your needs may vary depending upon the potential for exposure in of all know which require your workplace. | ON INGREDIENTS